Evidence map›Paper›PMID 29304023›Full record

ArticleMaterials (Basel, Switzerland)2018

Insulin Inclusion into a Tragacanth Hydrogel: An Oral Delivery System for Insulin.

Mokhamad Nur, Todor Vasiljevic

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Mokhamad NurAdvanced Food Systems Research Unit, College of Health and Biomedicine, Victoria University, PO Box 14428, Melbourne 8001, Australia. mokhamad.nur@live.vu.edu.au.ORCID 0000-0003-2421-7610
Todor VasiljevicAdvanced Food Systems Research Unit, College of Health and Biomedicine, Victoria University, PO Box 14428, Melbourne 8001, Australia. todor.vasiljevic@vu.edu.au.
University of Brawijaya · IDVictoria University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanoparticles or microparticles created by physical complexation between two polyelectrolytes may have a prospective use as an excipient for oral insulin administration. Natural polymers such as tragacanth, alginate, dextran, pullulan, hyaluronic acid, gelatin and chitosan can be potential candidates for this purpose. In this research, insulin particles were prepared by the inclusion of insulin into a tragacanth hydrogel. The effect of the pH and concentration relationship involving polyelectrolytes offering individual particle size and zeta potential was assessed by zetasizer and scanning electron microscopy (SEM). Insulin-tragacanth interactions at varying pH (3.7, 4.3, 4.6, or 6), and concentration (0.1%, 0.5%, or 1% w/w) were evaluated by differential scanning calorimetry (DSC) and ATR Fourier transform infrared (ATR-FTIR) analysis. Individual and smaller particles, approximately 800 nm, were acquired at pH 4.6 with 0.5% of tragacanth. The acid gelation test indicated that insulin could be entrapped in the physical hydrogel of tragacanth. DSC thermograms of insulin-tragacanth showed shifts on the same unloaded tragacanth peaks and suggested polyelectrolyte-protein interactions at a pH close to 4.3-4.6. FTIR spectra of tragacanth-insulin complexes exhibited amide absorption bands featuring in the protein spectra and revealed the creation of a new chemical substance.

Indexed as

biopolymersdrug deliverygum tragacanthhydrogelsinsulininsulin carrierPECpeptidesproteinrheology

Identifiers

PMID29304023
PMCPMC5793577
OpenAlexW2782619329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.